119 related articles for article (PubMed ID: 18306415)
21. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
22. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems.
Gitto S; Lorenzini S; Biselli M; Conti F; Andreone P; Bernardi M
Dig Liver Dis; 2009 Oct; 41(10):700-6. PubMed ID: 19502118
[TBL] [Abstract][Full Text] [Related]
23. Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease.
Lee JH; Kweon OJ; Lee MK; Lee HW; Kim HJ; Kim HR
Int J Hematol; 2015 Aug; 102(2):163-9. PubMed ID: 26068391
[TBL] [Abstract][Full Text] [Related]
24. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
[TBL] [Abstract][Full Text] [Related]
25. Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions.
Bambha KM; Biggins SW
Curr Opin Organ Transplant; 2008 Jun; 13(3):227-33. PubMed ID: 18685308
[TBL] [Abstract][Full Text] [Related]
26. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond.
Huo TI; Lee SD; Lin HC
Liver Int; 2008 May; 28(5):606-13. PubMed ID: 18433390
[TBL] [Abstract][Full Text] [Related]
27. Cirrhosis: caring for patients with end-stage liver failure.
Kelso LA
Nurse Pract; 2008 Jul; 33(7):24-30; quiz 30-1. PubMed ID: 18600168
[No Abstract] [Full Text] [Related]
28. External quality assessment for prothrombin time/international normalised ratio using point-of-care devices: split-sample or conventional external quality assessment using control samples?
Kitchen D; Murray E; Kitchen S; Jennings I; Fitzmaurice D; Woods T; Walker I
Scand J Clin Lab Invest; 2007; 67(7):673-5; author reply 676-7. PubMed ID: 17963156
[No Abstract] [Full Text] [Related]
29. External quality assessment of CoaguChek point-of-care testing prothrombin time/international ratio monitors.
Kitchen S; Kitchen D; Jennings I; Woods T; Walker I
Am J Clin Pathol; 2008 May; 129(5):825-6. PubMed ID: 18481407
[No Abstract] [Full Text] [Related]
30. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.
Medici V; Rossaro L; Wegelin JA; Kamboj A; Nakai J; Fisher K; Meyers FJ
Liver Transpl; 2008 Aug; 14(8):1100-6. PubMed ID: 18668666
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of prothrombin time in primary health care].
Trydal T; Bolann B; Brosstad F; Sandberg S; Sandset PM; Stavelin A; Steensland H; Thue G; Ødegaard OR
Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2048-9. PubMed ID: 16100552
[No Abstract] [Full Text] [Related]
32. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
[TBL] [Abstract][Full Text] [Related]
33. Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?
Sundaram V; Al-Osaimi AM; Lewis JJ; Lisman T; Caldwell SH
Dig Dis Sci; 2006 Jul; 51(7):1203-5. PubMed ID: 16944010
[No Abstract] [Full Text] [Related]
34. Prothrombin time and partial thromboplastin time assay considerations.
Ng VL
Clin Lab Med; 2009 Jun; 29(2):253-63. PubMed ID: 19665677
[TBL] [Abstract][Full Text] [Related]
35. Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful?
Barcellona D; Fenu L; Cornacchini S; Marongiu F
Thromb Res; 2009 Mar; 123(5):775-9. PubMed ID: 18814903
[TBL] [Abstract][Full Text] [Related]
36. The SmartCheck INR system.
Gardiner C
Am J Clin Pathol; 2008 May; 129(5):826. PubMed ID: 18481408
[No Abstract] [Full Text] [Related]
37. CoaguChek point-of-care testing prothrombin time monitors.
Braun SL
Am J Clin Pathol; 2007 Oct; 128(4):671-2; author reply 672. PubMed ID: 17924500
[No Abstract] [Full Text] [Related]
38. [Seventy years later: prothrombin time revisited].
Reber G; Boehlen F
Rev Med Suisse; 2008 Feb; 4(143):350-3. PubMed ID: 18386671
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
Strople J; Lovell G; Heubi J
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
[TBL] [Abstract][Full Text] [Related]
40. Intrahospital correlation of the international normalized ratio.
Lazo-Langner A; Villa-Márquez R; Hernández-Hernández D; Rojas-Maya S; Piedras J
Clin Appl Thromb Hemost; 2009; 15(2):220-4. PubMed ID: 18385150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
